Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Marvaso

Showing results (121-130 of 163) with videos related to

Pageof 17
Sort By:
Cancers|January 11, 2025
RadiOnCOVID: Multicentric Analysis of the Impact of COVID-19 on Patients Undergoing Radiation Therapy in ItalyAndrea Emanuele Guerini, Giulia Marvaso, Sandro Tonoli, et al.
Tumori|April 26, 2021
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparisonRaffaella Cambria, Delia Ciardo, Alessia Bazani, et al.
Biomedicines|December 23, 2023
Oral Surgery and Osteoradionecrosis in Patients Undergoing Head and Neck Radiation Therapy: An Update of the Current LiteratureGiulia Corrao, Giovanni Carlo Mazzola, Niccolò Lombardi, et al.
European Urology Oncology|December 16, 2025
Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation TherapyFederico Mastroleo, Riccardo Villa, Mattia Zaffaroni, et al.
BMC Cancer|September 11, 2019
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)Giulia Marvaso, Delia Ciardo, Giulia Corrao, et al.
La Radiologia Medica|September 17, 2018
Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionationBarbara Alicja Jereczek-Fossa, Alessia Surgo, Patrick Maisonneuve, et al.
Clinical and Translational Radiation Oncology|July 21, 2025
Prostate radiotherapy in patients with metastatic hormone-sensitive prostate cancer: A systematic review and <i>meta</i>-analysis of randomised controlled trialsNavid Roessler, Marcin Miszczyk, Alessandro Dematteis, et al.
Life (Basel, Switzerland)|July 27, 2024
Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve PatientsRiccardo Santamaria, Mattia Zaffaroni, Maria Giulia Vincini, et al.
La Radiologia Medica|October 9, 2019
Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionationBarbara Alicja Jereczek-Fossa, Alessia Surgo, Patrick Maisonneuve, et al.
Medical Oncology (Northwood, London, England)|July 30, 2020
Phase II prospective trial "Give Me Five" short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on quality of life (AIRC IG-13218)Giulia Marvaso, Simone Giovanni Gugliandolo, Federica Bellerba, et al.
Pageof 17

Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Cancers|January 11, 2025
RadiOnCOVID: Multicentric Analysis of the Impact of COVID-19 on Patients Undergoing Radiation Therapy in ItalyAndrea Emanuele Guerini, Giulia Marvaso, Sandro Tonoli, et al.
Tumori|April 26, 2021
Ultrahypofractionated radiotherapy for localized prostate cancer with simultaneous boost to the dominant intraprostatic lesion: a plan comparisonRaffaella Cambria, Delia Ciardo, Alessia Bazani, et al.
Biomedicines|December 23, 2023
Oral Surgery and Osteoradionecrosis in Patients Undergoing Head and Neck Radiation Therapy: An Update of the Current LiteratureGiulia Corrao, Giovanni Carlo Mazzola, Niccolò Lombardi, et al.
European Urology Oncology|December 16, 2025
Prostate-specific Antigen Nadir and Time to Nadir Predict Recurrence in Postprostatectomy Patients Treated with Salvage Radiotherapy Without Androgen Deprivation TherapyFederico Mastroleo, Riccardo Villa, Mattia Zaffaroni, et al.
BMC Cancer|September 11, 2019
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)Giulia Marvaso, Delia Ciardo, Giulia Corrao, et al.
La Radiologia Medica|September 17, 2018
Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionationBarbara Alicja Jereczek-Fossa, Alessia Surgo, Patrick Maisonneuve, et al.
Clinical and Translational Radiation Oncology|July 21, 2025
Prostate radiotherapy in patients with metastatic hormone-sensitive prostate cancer: A systematic review and <i>meta</i>-analysis of randomised controlled trialsNavid Roessler, Marcin Miszczyk, Alessandro Dematteis, et al.
Life (Basel, Switzerland)|July 27, 2024
Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve PatientsRiccardo Santamaria, Mattia Zaffaroni, Maria Giulia Vincini, et al.
La Radiologia Medica|October 9, 2019
Correction to: Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionationBarbara Alicja Jereczek-Fossa, Alessia Surgo, Patrick Maisonneuve, et al.
Medical Oncology (Northwood, London, England)|July 30, 2020
Phase II prospective trial "Give Me Five" short-term high precision radiotherapy for early prostate cancer with simultaneous boost to the dominant intraprostatic lesion: the impact of toxicity on quality of life (AIRC IG-13218)Giulia Marvaso, Simone Giovanni Gugliandolo, Federica Bellerba, et al.
Pageof 17